Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Avoid PZ Cussons (PZC) by Steve Moore in ShareProphets
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Sell Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Sell The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Naked Wines (WINE) by Steve Moore in ShareProphets
- Sell Mirriad Advertising (MIRI) by Steve Moore in ShareProphets
- Hold M&G (MNG) by Cliff D'Arcy in The Motley Fool
- Buy Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
- Outperform OSB Group (OSB) by RBC Capital
- Buy Diageo (DGE) by Harvey Jones in The Motley Fool
- Watch Nexteq (NXQ) by Steve Moore in ShareProphets
- Overweight Jet2 (JET2) by Barclays
- Outperform IntegraFin Holding (IHP) by RBC Capital
- Outperform Volution Group (FAN) by RBC Capital
- Sector Perform Currys (CURY) by RBC Capital
MGC Pharmaceuticals Limited NPV (DI) (MXC) Share Price
Health Care Sector
NOTE: This is based on 9 open tips for MGC Pharmaceuticals Limited NPV (DI) (MXC)
| Latest Bid : 21.00p | Latest Ask : 23.00p |
| High Today : 22.90p | Low Today : 21.10p |
| This Years High : 550.00p | This Years Low : 18.00p |
| Volume : 3,655 | MKT Cap : £722.92M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
MGC Pharmaceuticals Limited NPV (DI) (MXC) Overview
MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.MGC Pharmaceuticals Limited NPV (DI) (MXC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Speculative Buy | Canaccord Genuity | Premium Only | 2023-03-22 13:31:00 22/03/2023 | -96.00% |
| Sell | Tom Winnifrith | Premium Only | 2023-02-03 10:55:00 03/02/2023 | 96.00% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-04 17:10:00 04/09/2022 | 97.85% |
| Sell | Tom Winnifrith | Premium Only | 2022-07-08 12:00:00 08/07/2022 | 97.54% |
| Sell | Tom Winnifrith | Premium Only | 2022-06-16 16:00:00 16/06/2022 | 97.80% |
MGC Pharmaceuticals Limited NPV (DI) (MXC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 21.00p | Latest Ask : 23.00p |
| High Today : 22.90p | Low Today : 21.10p |
| This Years High : 550.00p | This Years Low : 18.00p |
| Volume : 3,655 | MKT Cap : £722.92M |
MGC Pharmaceuticals Limited NPV (DI) Overview
MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest MGC Pharmaceuticals Limited NPV (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Speculative Buy | Canaccord Genuity | Premium Only | 2023-03-22 13:31:00 22/03/2023 | -96.00% |
| Sell | Tom Winnifrith | Premium Only | 2023-02-03 10:55:00 03/02/2023 | 96.00% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-04 17:10:00 04/09/2022 | 97.85% |
| Sell | Tom Winnifrith | Premium Only | 2022-07-08 12:00:00 08/07/2022 | 97.54% |
| Sell | Tom Winnifrith | Premium Only | 2022-06-16 16:00:00 16/06/2022 | 97.80% |